Get the Stockscreener App
0.2039
1.44%
0.0029
After Hours:
.20
-0.0039
-1.91%
China Pharma Holdings Inc. Stock (CPHI) Latest News
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace
China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex
Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex
Big Pharma is remaining quiet on Trump's Chinese tariffs - Yahoo Finance
China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance
China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
Ascentage Pharma Prices U.S. IPO At $17.25/ADS - RTTNews
Asia Hedge Funds Post Biggest Annual Returns Since the Pandemic - Bloomberg
Henlius Biotech shareholders reject take-private offer from China's Fosun - Reuters.com
Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year - Yahoo Finance
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
‘The bar has risen’: China’s biotech gains push US companies to adapt - BioPharma Dive
Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update - Defense World
The top 10 biopharma M&A deals of 2024 - FiercePharma
Dry Eye Products Market Opportunities and Strategies to - GlobeNewswire
Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - MSN
Barclays PLC Has $759,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World
China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
China Pharma Holdings, Inc. Rescinds Securities Purchase Agreement - Defense World
PetVivo Holdings, Inc. to Make Investor Presentations - Defense World
Keen Vision Acquisition Extends Business Combination PeriodKeen Vision Acquisition Corporation (NASDAQ: KVAC) has recently filed a Form 8-K with the Securities and Exchange Commission, announcing the extension of its business combination period. T - Defense World
AmpliTech Group Enters Securities Purchase Agreement with Institutional InvestorsWASHINGTON, D.C., December 24, 2024 – AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed today in an 8-K filing with the Securities and Exchange Commission that it has - Defense World
Blackboxstocks Inc. Dismisses Turner, Stone & Company as Independent Registered Public Accounting Firm; Engages Victor Mokuolo CPA PLLC as ReplacementOn December 20, 2024, Blackboxstocks Inc. (NASDAQ: BLBX) made significant changes in its a - Defense World
The Glimpse Group Announces Closing of $7.29 Million OfferingWASHINGTON, D.C., December 23, 2024 – The Glimpse Group, Inc. (NASDAQ:VRAR) disclosed the finalization of a registered direct offering on December 23, 2024. The undertaking involved a - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Analysts Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $50.28 - Defense World
China Pharma Holdings, Inc. Successfully Conducts Annual Stockholders’ Meeting - Defense World
GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World
**Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth** - Defense World
Wrap Technologies Reports Approval of Incentive Plan Amendment and Director Elections at Annual Meeting - Defense World
Financial Review: Autozi Internet Technology (Global) (NASDAQ:AZI) vs. Driven Brands (NASDAQ:DRVN) - Defense World
Aker BP ASA (OTCMKTS:AKRBF) Trading Down 1.7% – Here’s What Happened - Defense World
Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World
Financial Survey: Flagstar Financial (FLG) and Its Peers - Defense World
White Gold Corp. (OTCMKTS:WHGOF) Short Interest Down 99.3% in December - Defense World
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
HighTower Advisors LLC Grows Holdings in American Century STOXX U.S. Quality Growth ETF (NYSEARCA:QGRO) - Defense World
Items Tagged with 'Jeil Pharma Holdings Inc.' - BioWorld Online
Hengrui Pharma accelerates bid for global brand status - Bamboo Works
China Pharma settles convertible note obligations By Investing.com - Investing.com Australia
China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville - Citizentribune
China Pharma settles convertible note obligations - Investing.com
China Pharma (CPHI) Strengthens Balance Sheet with Early $5.25M Convertible Note Redemption - StockTitan
Merck enters obesity drug race in pact with Chinese pharma Hansoh - Seeking Alpha
Act Fast and You Can Still Enroll In An ACA Healthcare Plan for 2025 - 69News WFMZ-TV
With Correct Measurements, Wine Really May Protect Heart - 69News WFMZ-TV
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist - Yahoo Finance
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights - Yahoo Finance
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
U.S. Energy Enters Purchase and Sale Agreement with 84 Resources Holdings: Date of Agreement December 12, 2024 - Defense World
Werner Enterprises, Inc. (NASDAQ:WERN) Given Average Recommendation of “Reduce” by Brokerages - Defense World
NewAmsterdam Pharma (NASDAQ:NAMS) Enters into Underwriting Agreement for Public OfferingNEW YORK–(BUSINESS WIRE)– December 13, 2024– NewAmsterdam Pharma Company N.V. (NAMS) announced today the completion of an underwritten pub - Defense World
2.34%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):